RNPGX
Price
$67.37
Change
-$0.25 (-0.37%)
Updated
Jun 5 closing price
Net Assets
150.71B
RPEBX
Price
$65.22
Change
-$0.24 (-0.37%)
Updated
Jun 5 closing price
Net Assets
150.71B
Interact to see
Advertisement

RNPGX vs RPEBX

Header iconRNPGX vs RPEBX Comparison
Open Charts RNPGX vs RPEBXBanner chart's image
American Funds New Perspective R6
Price$67.37
Change-$0.25 (-0.37%)
VolumeN/A
Net Assets150.71B
American Funds New Perspective R2E
Price$65.22
Change-$0.24 (-0.37%)
VolumeN/A
Net Assets150.71B
RNPGX vs RPEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNPGX vs. RPEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNPGX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPGX (151B) and RPEBX (151B) have equal amount of cash in the bank . RNPGX pays higher dividends than RPEBX: RNPGX (0.82) vs RPEBX (0.13). RNPGX was incepted earlier than RPEBX: RNPGX (16 years) vs RPEBX (11 years). RPEBX (1.21) is less costly to investors than RNPGX (0.41). RNPGX (24.00) and RPEBX (24.00) have comparable annual turnover. RNPGX (250) and RPEBX (250) have matching initial minimum investment requirements. RNPGX annual gain was more profitable for investors over the last year : 9.61 vs. RPEBX (8.61). RNPGX return over 5 years is better than : 45.22 vs. RPEBX (40.47).
RNPGXRPEBXRNPGX / RPEBX
Total Expense Ratio0.411.2134%
Annual Report Gross Expense Ratio0.411.2134%
Fund Existence16 years11 years-
Gain YTD8.8018.431104%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets151B151B100%
Annual Yield % from dividends0.820.13639%
Returns for 1 year9.618.61112%
Returns for 3 years30.2327.83109%
Returns for 5 years45.2240.47112%
Returns for 10 years79.8571.21112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOVX0.470.01
+2.84%
Theriva Biologics Inc
KROS15.110.29
+1.96%
Keros Therapeutics
GLNG41.820.60
+1.46%
Golar Lng Ltd
GLSI9.360.02
+0.21%
Greenwich LifeSciences
PODD317.16-2.05
-0.64%
Insulet Corp